Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
KCNJ2 Blocking Peptide (AC1368)
Cat.#: ACPP-1368
Specifications
Despition KCNJ2 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1202 Pin1 Blocking Peptide (AC1202) 250 µg inquiry ACPP-1010 Synthetic Nanodisc Human GPR56 Protein (AC1010) 10 µg inquiry ACPP-1041 Recombinant Human Wnt3a Protein (AC1041) 50 µg inquiry ACPP-1470 Human CLTA Protein (AC1470) 5 µg inquiry ACPP-1133 Synthetic Nanodisc Human OR52D1 Protein (AC1133) 10 µg inquiry ACPP-1189 PDE6C Blocking Peptide (AC1189) 250 µg inquiry ACPP-1498 Human LIN7A Protein (AC1498) 2 µg inquiry ACPP-1192 Human WNT3A Protein (AC1192) 5 µg inquiry ACPP-1212 PAX8 Blocking Peptide (AC1212) 250 µg inquiry ACPP-1517 Human PGRN Protein (AC1517) 2 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket